Familial hypertriglyceridemia: Difference between revisions
CSV import |
CSV import |
||
| Line 33: | Line 33: | ||
{{stub}} | {{stub}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | |||
Revision as of 17:11, 10 February 2025
Familial hypertriglyceridemia is a genetic disorder that results in high levels of triglycerides in the blood. This condition is inherited in an autosomal dominant manner, meaning that an affected person has a 50% chance of passing the disorder onto their children.
Symptoms
The symptoms of familial hypertriglyceridemia can vary greatly from person to person. Some people may not experience any symptoms at all, while others may experience symptoms such as xanthomas (fatty deposits under the skin), pancreatitis (inflammation of the pancreas), and hepatosplenomegaly (enlargement of the liver and spleen).
Causes
Familial hypertriglyceridemia is caused by mutations in the lipoprotein lipase (LPL) gene. This gene provides instructions for making an enzyme that plays a crucial role in the breakdown of triglycerides. Mutations in the LPL gene disrupt the function of this enzyme, leading to an accumulation of triglycerides in the blood.
Diagnosis
Diagnosis of familial hypertriglyceridemia is based on a physical examination, medical history, and blood tests to measure the levels of triglycerides in the blood. Genetic testing may also be performed to confirm the diagnosis.
Treatment
Treatment for familial hypertriglyceridemia primarily involves lifestyle changes such as a low-fat diet and regular exercise. Medications may also be prescribed to help lower triglyceride levels.
See also
References
<references />



